Madrigal Pharmaceuticals Inc

Madrigal Pharmaceuticals Inc is a biopharmaceutical firm focused on the discovery, development, and commercialisation of novel therapies. These therapies are for the treatment of cardiovascular, metabolic, and liver diseases. With global operations, the company is committed to fighting the world's most pressing health issues. Within the biotechnology industry, Madrigal is known for its innovative approach and therapeutic solutions. Madrigal Pharmaceuticals operates as an independent entity. The company's key drug therapies target thyroid hormone receptors, often associated with various heart and metabolic diseases, offering potential for both investors and patients. Diversify your virtual portfolio by following MDGL shares on eToro.